Skip to main content

Organogenesis Holdings Inc.

ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001661181

No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Organogenesis Holdings Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ORGO: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders108124+16
Shares58.3M57.1M−1.21M (−2.1%)
Value$238.3M$162.0M−$76.3M (−32.0%)

New holders (28)

Institutions that held Organogenesis Holdings Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Sold out (12)

Institutions that held Organogenesis Holdings Inc. at the end of Q4 2023 and filed for Q1 2024 without it.